Objectives 

• By working closely with other IFAPP WGs and external bodies such as nationally and internationally operating bodies (e.g. FPM², CIOMS³) and also by involving senior experts in PM engaged in IFAPP (e.g. Past Presidents, GFMD⁴) and Individual Affiliates, ECWG will enhance the discipline of PM by attracting more skilled and well trained people from different disciplines and enabling them to develop effective and safer drugs for the patients.

• ECWG will interact closely with its National Member Associations in the various regions in the world and support region-specific affordable training courses and will make every attempt to endorse and ensure their recognition and certification on either a national, regional or, if possible, on a global level.

• New and affordable online learning possibilities will be explored and endorsed so that IFAPP's membership in many countries of the world can profit from these.

• ECWG will foster the recognition of educational programmes in order to advance the discipline of PM.

• Latest requirements from medicines regulatory agencies  (e.g. EMA, FDA, national governmental bodies) will be taken into account and IFAPP will thrive to ensure the most up-to-date contents in these educational programmes.

Measures

Concrete measures will be laid down in a work plan drafted by the group and reviewed on an annual basis.

 

¹ PharmaTrain https://www.pharmatrain.eu/news.php; https://ifapp.org/about/pharmatrain-syllabus
² FPM               Faculty of Pharmaceutical Medicine of the Royal Colleges of the United Kingdom
³ CIOMS           Council for International Organisations of Medical Sciences
⁴ GFMD            Global Fellow in Medicines Development

 

Click here for the Call for Applications on the IFAPP News page.